Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutra Pharma, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and Pain, has selected Nutritional Alliance to serve as its sales agent for its Nyloxin pain relievers.
Subscribe to our email newsletter
Founded in 2000, Nutritional Alliance is a sales brokerage firm specialising in products intended for drug, food and mass distribution as well as products intended for medical distribution.
Nutra Pharma chairman and CEO Rik Deitsch said that they were pleased to introduce Nutritional Alliance as their sales agent.
"This is a natural continuation of our product launches that began with the introduction of Cobroxin last November," Deitsch said.
"Over the past several months, we have worked with Nutritional Alliance to prepare for our domestic launch of Nyloxin through one of the healthcare product distributors, Henry Schein."